Security record · archived quarter
VIR
Vir Biotechnology, Inc. · Healthcare · Biotechnology
12Tracked holders
n/aΔ holders
10.84MShares held
$96.49MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 20.43K | $227,193 | n/a | n/a |
| Q2 2026 | 87 | -1 | 78.79M | $802.94M | +8 | −9 |
| Q1 2026 | 91 | +1 | 69.76M | $624.09M | +9 | −8 |
| Q4 2025 | 90 | +1 | 66.65M | $401.74M | +1 | n/a |
| Q3 2025 | 15 | 0 | 49.25M | $281.20M | n/a | n/a |
| Q2 2025 | 12 | 0 | 46.48M | $234.27M | n/a | n/a |
| Q1 2025 | 9 | -2 | 12.32M | $79.81M | n/a | −2 |
| Q4 2024 | 11 | 0 | 12.20M | $89.54M | +1 | −1 |
| Q3 2024 | 10 | -2 | 8.42M | $63.10M | n/a | −2 |
| Q2 2024 | 12 | n/a | 10.84M | $96.49M | n/a | n/a |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 3.92M | n/a | $34.90M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 2 | Geode Capital Management ✦ (passive) | 2.18M | n/a | $19.44M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 3 | Renaissance Technologies ✦ | 1.33M | n/a | $11.83M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Millennium Management ✦ | 1.25M | n/a | $11.11M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 922.55K | n/a | $8.21M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 6 | Citadel Advisors ✦ | 749.99K | n/a | $6.67M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 7 | Two Sigma Investments ✦ | 356.55K | n/a | $3.17M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 57.84K | n/a | $515,000 | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Norges Bank ✦ (passive) | 28.90K | n/a | $257,210 | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Point72 Asset Management ✦ | 17.60K | n/a | $156,640 | 0.0% | n/c | 1 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 15.04K | n/a | $133,829 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 12 | Gotham Asset Management ✦ | 10.15K | n/a | $90,317 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 251 holders, 138.04M shares, $1.23B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Aug 07
SC 13G: STATE STREET CORP
Jul 31
SC 13G/A: VANGUARD PORTFOLIO MANAGEMENT LLC
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API